We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-8.74%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.03B
AUM Growth
-$97.2M
Cap. Flow
+$5.15M
Cap. Flow %
0.5%
Top 10 Hldgs %
54.98%
Holding
5,775
New
1,132
Increased
1,485
Reduced
1,487
Closed
1,545

Sector Composition

Rank Sector Weight
1 Financials 2.17%
2 Healthcare 1.69%
3 Industrials 1.67%
4 Technology 1.59%
5 Consumer Discretionary 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENFY
3401
DELISTED
Enlightify Inc
ENFY
$2K ﹤0.01%
+111
New +$2.52K
AAMI
3402
Acadian Asset Management
AAMI
$3.22B
$2K ﹤0.01%
138
-2,600
-95% -$43.9K
SPLP
3403
DELISTED
STEEL PARTNERS HOLDINGS L.P.
SPLP
$2K ﹤0.01%
+100
New +$1.7K
EGF
3404
DELISTED
Blackrock Enhanced Government Fund, Inc.
EGF
$2K ﹤0.01%
134
-171
-56% -$2.33K
CNSL
3405
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$2K ﹤0.01%
92
-2,974
-97% -$59.4K
NDP
3406
DELISTED
TORTOISE ENERGY INDEPENDENCE FUND, INC.
NDP
$2K ﹤0.01%
+17
New +$2.09K
WHLM
3407
DELISTED
Wilhelmina International, Inc
WHLM
$2K ﹤0.01%
343
+173
+102% +$1.01K
VTNR
3408
DELISTED
Vertex Energy, Inc
VTNR
$2K ﹤0.01%
797
+697
+697% +$1.54K
VBIV
3409
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$2K ﹤0.01%
31
+30
+3,000% +$2.38K
MRNS
3410
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$2K ﹤0.01%
+50
New +$2.82K
OPGN
3411
DELISTED
OpGen, Inc
OPGN
0
YTEN
3412
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
0
AENZ
3413
DELISTED
Aenza S.A.A.
AENZ
$2K ﹤0.01%
152
-1,121
-88% -$17.1K
AVID
3414
DELISTED
Avid Technology Inc
AVID
$2K ﹤0.01%
+200
New +$2.06K
CEQP
3415
DELISTED
Crestwood Equity Partners LP
CEQP
$2K ﹤0.01%
+80
New +$2.61K
SPPI
3416
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$2K ﹤0.01%
253
-2,934
-92% -$20.4K
TCFC
3417
DELISTED
The Community Financial Corporation Common Stock
TCFC
$2K ﹤0.01%
+65
New +$1.4K
SNMP
3418
DELISTED
Evolve Transition Infrastructure LP
SNMP
$2K ﹤0.01%
+7
New +$2.15K
SIRE
3419
DELISTED
Sisecam Resources LP
SIRE
$2K ﹤0.01%
100
+35
+54% +$808
EXD
3420
DELISTED
Eaton Vance TaxManaged Buy-Write Strategy Fund
EXD
$2K ﹤0.01%
+180
New +$2.28K
RFP
3421
DELISTED
Resolute Forest Products Inc.
RFP
$2K ﹤0.01%
200
-4,239
-95% -$41.1K
SRNE
3422
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$2K ﹤0.01%
200
-2,269
-92% -$36.1K
REED
3423
DELISTED
Reeds, Inc. Common Stock
REED
$2K ﹤0.01%
7
+3
+75% +$835
SMIT
3424
DELISTED
Schmitt Industries Inc
SMIT
$2K ﹤0.01%
609
+405
+199% +$1.16K
ZVO
3425
DELISTED
Zovio Inc. Common Stock
ZVO
$2K ﹤0.01%
256
-1,506
-85% -$12.9K

Similar funds

Tower Research Capital (TRC)'s Q3 2015 Portfolio in Review

As of Q3 2015, Tower Research Capital (TRC) held 5,775 positions worth $1.03B, down 8.6% from $1.13B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Tower Research Capital (TRC)'s Q3 2015 filing shows 1,132 new, 1,485 increased, 1,487 reduced and 1,545 closed positions. Its largest new stake was iShares Russell 2000 ETF: 144,546 shares worth $15.8M. The largest sale was VanEck Semiconductor ETF, an estimated $34M.

By sector, the portfolio is most concentrated in Financials at 2.2% of assets, down from 2.5% a quarter earlier, followed by Healthcare and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2015 buy was iShares Russell 2000 ETF: 144,546 shares worth $15.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q3 2015, an estimated $37.1M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2015 reduction was VanEck Semiconductor ETF, cutting an estimated $34M.
  • Tower Research Capital (TRC) fully exited Vanguard Extended Market ETF in Q3 2015, selling an estimated $10M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 55% of its $1.03B portfolio in Q3 2015.
  • Tower Research Capital (TRC) opened 1,132 new positions and closed 1,545 in Q3 2015.
  • Tower Research Capital (TRC)'s portfolio value fell 8.6% quarter-over-quarter to $1.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2015, filed 13 Nov 2015.